CD72T,

Jing Yang1, Chengyong Ma2, Zhongxue Feng1

  • 1Institute of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, China.

PubMed
概括

溶性CD72 (sCD72) 通过抑制T细胞适应性免疫力,加剧败血症. 这项研究揭示了sCD72作为败血症诱导免疫抑制的关键调解者,提供潜在的诊断和治疗点.